Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell World Chess (CHSS) by Steve Moore in ShareProphets
- Avoid Trifast (TRI) by Steve Moore in ShareProphets
- Avoid The Magnum Ice Cream Company (MICC) by Steve Moore in ShareProphets
- Buy Relx plc (REL) by Bank of America
- Buy South32 Limited (DI) (S32) by UBS
- Buy Weir Group (WEIR) by UBS
- Buy Relx plc (REL) by UBS
- Avoid Iomart Group (IOM) by Steve Moore in ShareProphets
- Buy Halma (HLMA) by Goldman Sachs
- Sell Ashmore Group (ASHM) by Deutsche Bank
- Hold Mondi (MNDI) by Deutsche Bank
- Hold Schroders (SDR) by Deutsche Bank
- Buy Relx plc (REL) by Deutsche Bank
- Buy Morgan Sindall Group (MGNS) by Deutsche Bank
- Hold GSK (GSK) by Deutsche Bank
- Overweight Unilever (ULVR) by Barclays
- Buy Morgan Sindall Group (MGNS) by Berenberg
- Outperform Rathbones Group (RAT) by RBC Capital
- Overweight Relx plc (REL) by Barclays
- Outperform Relx plc (REL) by Bernstein
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,256 open tips for AstraZeneca (AZN)
| Latest Bid : 15,114.00p | Latest Ask : 15,118.00p |
| High Today : 15,186.00p | Low Today : 14,812.00p |
| This Years High : 15,186.00p | This Years Low : 9,667.00p |
| Volume : 5,095,901 | MKT Cap : £234329M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Berenberg | Premium Only | 2026-01-28 05:24:00 28/01/2026 | 9.41% |
| Buy | Citi | Premium Only | 2026-01-27 05:33:00 27/01/2026 | 9.55% |
| Buy | Shore Capital | Premium Only | 2026-01-16 14:46:00 16/01/2026 | 7.79% |
| Buy | UBS | Premium Only | 2026-01-16 08:57:00 16/01/2026 | 7.54% |
| Sell | Deutsche Bank | Premium Only | 2026-01-16 07:11:00 16/01/2026 | -7.83% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 15,114.00p | Latest Ask : 15,118.00p |
| High Today : 15,186.00p | Low Today : 14,812.00p |
| This Years High : 15,186.00p | This Years Low : 9,667.00p |
| Volume : 5,095,901 | MKT Cap : £234329M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Berenberg | Premium Only | 2026-01-28 05:24:00 28/01/2026 | 9.41% |
| Buy | Citi | Premium Only | 2026-01-27 05:33:00 27/01/2026 | 9.55% |
| Buy | Shore Capital | Premium Only | 2026-01-16 14:46:00 16/01/2026 | 7.79% |
| Buy | UBS | Premium Only | 2026-01-16 08:57:00 16/01/2026 | 7.54% |
| Sell | Deutsche Bank | Premium Only | 2026-01-16 07:11:00 16/01/2026 | -7.83% |